Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

In Vitro Fertilization Market will Reach USD 36.39 Billion by 2026: Increasing Cases of Infertility Among Men to Positively Influence Growth, says Fortune Business Insights™

Published

on

Pune, Feb. 20, 2020 (GLOBE NEWSWIRE) — The global In Vitro Fertilization (IVF) Market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined manually in laboratories. Various studies show that almost half a million babies are born by this process or other assistant reproductive processes. Such factors are responsible for the in vitro fertilization market growth.Fortune Business Insights™ latest report, titled, “In Vitro Fertilization (IVF) Market Size, Share & Industry Analysis, By Type (Conventional IVF, and IVF with ICSI), By Procedure (Fresh Non-donor, Frozen Non-donor, Fresh Donor, and Frozen Donor), By End User (Hospitals, and Fertility Clinics) and Regional Forecasts, 2019-2026” provides a 360-degree overview of the market and its parameters. These include growth drivers, restraints, challenges, and opportunities. The report also provides detailed segmentation of the market with market figures such as base and forecast figure and the compound annual growth rates (CAGRs) as well. Besides this, the report provides interesting insights into the market, key industry developments, and other IVF market trends. The report is available for sale on the company website.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/in-vitro-fertilization-ivf-market-102189


Adoption and Practice of Sedentary Lifestyle to Add Impetus to Market Growth
Nowadays, people are more inclined towards career goals rather than family planning, and therefore often tend to opt for late pregnancies. The increasing number of such cases is a major in vitro fertilizer market driver, as mentioned earlier, since complicated cases are often resolved by opting for IVF treatment. This is more common in nations such as the UK, Japan, and the U.S. Besides this, the rise in the number of male infertility is anticipated to increase the adoption of IVF treatment and thus accelerate the in vitro fertilization market size in the coming years. Besides this, government-supported reimbursement policies and awareness programs are aiding the overall in vitro fertilization market growth of the region.Analysts at Fortune Business Insights™ said” high expenses and risks related to the in vitro fertilization process (IVF) and Intracytoplasmic sperm injection (ICSI) may cause hindrance to the overall in vitro fertilization market revenue”. Nevertheless, factors such as increasing obesity cases among people, infertility among men, the practice of sedentary lifestyle, and others are likely to create lucrative IVF market growth opportunities in the coming years.Europe to Dominate the Market with Maximum Number of Treatment Cases RegisteredEurope holds a dominant in vitro fertilization market share with a revenue of USD 7.57 billion generated in the year 2018. This is attributable to the rise in the prevalence of infertility and the increasing popularity of IVF treatment in the region. On the other side, the market in North America will witness steady growth on account of the high cost associated with ICSI and IVF treatment. As per the FertilityIQ data, 2017, in the U.S., the average expenditure of a patient undergoing a single IVF cycle is USD 22,000. Thus, patients in the U.S are travelling to other countries for IVF treatment citing lower costs.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/in-vitro-fertilization-ivf-market-102189


Companies are Investing in Construction of New Fertility Centers for Revenue Generation
Boston IVF, Pelargos IVF, and Monash IVF are currently dominating the market. In vitro fertilization market manufacturers are developing new centers with efficient and high-quality treatment in remote locations for speeding their own revenue generation and making their mark in the market competition. This will ultimately accelerate the overall IVF market size.Significant Industry Developments in In Vitro Fertilization Market:May 2019 – A new embryo screening test was developed by scientists at Monash IVF for reducing the risk of miscarriage at the time of IVF treatment.July 2019 – The opening of a new full-service IVF center at the Westshore office at Tampa, Florida, was announced by Shady Grove Fertility. The main objective behind the opening of this center is to offer affordable and high-quality fertility treatment options to the regional people.List of key Companies Operating in the In Vitro Fertilization (IVF) Market include:Monash IVFOvation FertilityBloom IVF CentreShady Grove FertilityBangkok IVF centerBoston IVFPelargos IVFRSMCGroup Ambroise Paré ClinicOther Service Providers
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/in-vitro-fertilization-ivf-market-102189


Detailed Table of Content:
IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsPrevalence of Infertility, For Key Country/Region, 2018Number of IVF Procedures, For Key Country/Regions, 2018Number of Registered Fertility Clinics, For Key Countries, 2018Reimbursement Scenario, For Key Country/RegionKey Industry Developments, Partnerships, Mergers and AcquisitionGlobal In Vitro Fertilization (IVF) Market Analysis, Insights and Forecast, 2015-2026Key Findings / SummaryMarket Analysis, Insights and Forecast – By TypeConventional IVFIVF with ICSIMarket Analysis, Insights and Forecast – By ProcedureFresh Non-donorFrozen Non-donorFresh DonorFrozen DonorMarket Analysis, Insights and Forecast – By End UserHospitalsFertility ClinicsMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaTOC Continued….!

Request for Customization:  https://www.fortunebusinessinsights.com/enquiry/customization/in-vitro-fertilization-ivf-market-102189


Have a Look at Related Reports:
In-vitro Diagnostics (IVD) Market Size, Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 – 2026Assisted Reproductive Technology (ART) Market Size, Share & Industry Analysis, By Technique (In-Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), and Others), By Procedure (Fresh Donor, Fresh Non-donor, Frozen Donor, and Frozen Non-donor), By End User (Fertility Clinics, and Hospitals) and Regional Forecast, 2019-2026Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026Neuroendoscopy Devices Market Size, Share & Industry Analysis, By Product Type (Rigid Neuroendoscopes, Flexible Neuroendoscopes), By Application Type (Transnasal Neuroendoscopy, Intraventricular Neuroendoscopy, Transcranial Neuroendoscopy), By End User (Hospitals, Specialty Clinics, Others) and Regional Forecast, 2019-2026Next-Generation Sequencing (NGS) Market Size, Share and Industry Analysis By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Regional Forecast, 2019 – 2026Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Regional Forecast, 2019 – 2026Contract Research Organization (CRO) Services Market Size, Share and Industry Analysis By Service Type (Discovery, Pre-Clinical, Clinical, Laboratory Services), By Application (Oncology, Cardiology, Infectious Disease, Metabolic Disorders, Others), By End User (Pharmaceutical & Biotechnological Companies, Medical Device Companies, Academic & Research Institutes, Others), and Regional Forecast 2019-2026Immunology Market Size, Share and Industry Analysis By Drug Class (Monoclonal antibody (mAb), Fusion Proteins, Immunosuppressant, Polyclonal antibody (pAb), Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others), By Distribution Channel, and Regional Forecast 2019-2026Immunodiagnostics Market Size, Share and Industry Analysis By Product Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases), By End user (Clinical Laboratories, Hospitals, Physician’s Offices), By End-user(Hospitals, Dental Clinics, Academic & Research Institutes) and Regional Forecast, 2019 – 2026Orthobiologics Market Size, Share and Industry Analysis by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), By Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics), and Regional Forecast 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release:   https://www.fortunebusinessinsights.com/press-release/in-vitro-fertilization-ivf-market-9606

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Sentrycs Secures Multimillion-Dollar Deals to Protect Military Bases in Europe

Published

on

sentrycs-secures-multimillion-dollar-deals-to-protect-military-bases-in-europe

Sentrycs’ technology-leading counter-drone solutions have been chosen to enhance the protection of military bases in Europe against small and commercial drones
TEL AVIV, Israel, May 29, 2024 /PRNewswire/ — Sentrycs – a global technology leader in the cyber-based RF segment of counter-drone solutions – announced strategic deals which will see the implementation of its advanced counter-UAS (Unmanned Aerial Systems) solutions across multiple military bases throughout Europe.

 
The field-proven Israeli technology provider will enable its customers to mitigate the immediate threats from small and commercial drones performing ISR (Intelligence, Surveillance, and Reconnaissance) missions over sensitive sites including military bases, and occasionally attacking forces as demonstrated in recent years in Ukraine-Russia conflict and in the Middle East.
Sentrycs solutions, employing proprietary protocol analysis technology, can passively detect those drones, track their flight, identify their model, unique serial number, and ID, enabling distinction between friendly and enemy drones. Once a drone becomes a threat, the system neutralizes the drone, landing it safely in a predefined zone.
The systems will be deployed either as a standalone or as an integral part of broader multi-layered C-UAS solution to enable effective protection against different kinds of drones.
“Winning these projects signifies a meaningful market recognition of Sentrycs’ unique capabilities and technology leadership,” said Yoav Zaltzman, CEO of Sentrycs. “Our commitment to ongoing innovation and our agility in adapting to the fast-changing threats, along with strong customer support allow us to provide a field-proven and effective long-term solution. We are proud to contribute to the security of our allies with our advanced counter-drone solutions.”
ABOUT SENTRYCS:
Sentrycs is a leader in adaptive counter-drone solutions, supported by innovative cyber over RF technology. Sentrycs field-proven solutions are designed to passively detect, track, identify, and where necessary, mitigate unauthorized drones. It is custom-built for various environments, including airports, borders, prisons, critical infrastructure, and mass events. Founded in 2017, Sentrycs has offices in Israel and the US, serving customers worldwide. By uniting its field-proven technology and expertise in global drone environments, Sentrycs is leading the way toward a safer and more secure drone-driven future. Learn more at www.sentrycs.com.
Photo: https://mma.prnewswire.com/media/2422731/Sentrycs_Portable_Kit.jpgPhoto: https://mma.prnewswire.com/media/2422732/Sentrycs.jpgLogo: https://mma.prnewswire.com/media/2422730/Sentrycs_Logo.jpg
 
 

View original content:https://www.prnewswire.co.uk/news-releases/sentrycs-secures-multimillion-dollar-deals-to-protect-military-bases-in-europe-302157168.html

Continue Reading

Artificial Intelligence

SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing

Published

on

scibase-announces-the-launch-of-ebarrier-score,-the-first-ai-driven-skin-barrier-assessment-tool-for-research-and-cosmetic-testing

STOCKHOLM, May 29, 2024 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin disorders is pleased to announce the launch of the eBarrier Score for Nevisense, the first-ever AI skin barrier assessment tool built for use in research and cosmetic testing. The eBarrier Score was announced today at the Cosmetotest cosmetic testing symposium in Lyon, France.

Researchers of the skin barrier and cosmetic products can now use Nevisense and the eBarrier Score to assess products and claims related to skin barrier function. The global market for cosmetic products aiming to improve people’s skin barrier is experiencing immense growth.
Nevisense and the eBarrier Score utilize AI-generated algorithms that researchers can use to directly quantitate the severity of skin barrier dysfunction related to common skin disorders.
In a recently published study (Skin Barrier Function Assessment: Electrical Impedance Spectroscopy Is Less Influenced by Daily Routine Activities Than Transepidermal Water Loss – https://anndermatol.org/DOIx.php?id=10.5021/ad.23.052) the first direct comparison between electrical impedance spectroscopy (EIS) using Nevisense and trans-epidermal water loss (TEWL) was made. The study demonstrates Nevisense being a more robust technique to assess skin barrier function than the within research commonly used TEWL measurement technique.
“We are thrilled to introduce the eBarrier Score to the cosmetic research market,” said Pia Renaudin, CEO of SciBase. “Every day, there are new cosmetic products related to skin barrier function. The Nevisense eBarrier Score is already an established tool in the medical research field and bringing it to the cosmetic research market will truly benefit consumers.”
For more information on the eBarrier Score and SciBase’s other research or medical products, visit scibase.com. In February SciBase announced a partnership with Skinobs, a leading global platform connecting researchers with the tools they need for their cosmetic and medical research. Through this partnership, SciBase can now offer Nevisense and eBarrier for assessing skin barrier function within cosmetic testing on the Skinobs platform.
For additional information, please contact:Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected] Advisor (CA):Vator SecuritiesTel: +46 8 580 065 99Email: [email protected]
About SciBase:
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at www.scibase.com. All press releases and financial reports can be found here: http://investors.scibase.se/en/pressreleases
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/scibase/r/scibase-announces-the-launch-of-ebarrier-score–the-first-ai-driven-skin-barrier-assessment-tool-for,c3990203
The following files are available for download:
https://mb.cision.com/Main/12371/3990203/2828415.pdf
eBarrier Score PR
 

View original content:https://www.prnewswire.co.uk/news-releases/scibase-announces-the-launch-of-ebarrier-score-the-first-ai-driven-skin-barrier-assessment-tool-for-research-and-cosmetic-testing-302157613.html

Continue Reading

Artificial Intelligence

Warmflow to see more actionable real-time operational insights and better forecasting with Plex Smart Manufacturing Platform from Rockwell Automation

Published

on

warmflow-to-see-more-actionable-real-time-operational-insights-and-better-forecasting-with-plex-smart-manufacturing-platform-from-rockwell-automation

Irish family-owned home heating technology company to leverage cloud-based ERP, QMS & MES to empower its employees and enhance digital capabilities
BRUSSELS, May 29, 2024 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced that Warmflow, an innovative home heating technology company based in Lisburn, Northern Ireland, is to be the first company in Ireland to deploy the Plex ERP, QMS & MES solution from Rockwell Automation.

Established in 1970, Warmflow, a family-owned business, is committed to digital innovation. By adopting the Plex Smart Manufacturing Platform™, it is positioned to optimize operations, enhance efficiency, and stay ahead in an evolving marketplace. The Plex solution will replace several disparate systems with MES (manufacturing execution systems), ERP (enterprise resource planning), and QMS (quality management systems) under Plex’s single-platform cloud-based umbrella.
Primary outcomes are to include a significant reduction of capital investment in stock and more accurate production planning, both of which will be possible thanks to the real-time insight-driven forecasting.
“Warmflow is an ideal customer for our Plex solution,” said Asa Arvidsson, regional vice president north region, Rockwell Automation. “It is well suited for mid-size companies to support cross-functional processes, such as ERP, MES and QMS, and to deliver a single, integrated, and intuitive view of manufacturing operations. Its cloud-based architecture also makes it eminently scalable and faster to implement.”
The digital transformation project – including new sequencing automation, control, I/O, and associated code – was developed in collaboration with ControlSoft Automation Systems, a member of the Rockwell Automation PartnerNetwork™ ecosystem as a gold-level system integrator. ControlSoft is an industrial automation company based in Dundalk, Co. Louth, Ireland, that provides turnkey solutions for process control, machine control, information, and energy control for many industries.
An important element of this turnkey project was the development of a value engineering assessment report that examined the current situation and then compared it with typical results from the Plex solution over a five-year period. Substantial savings and a rapid return on investment (ROI) were immediately apparent by removing scheduling and stockholding pain points and providing more efficient automated data handling.
“We are a family-owned business, providing innovative heating solutions to the community for the last 50 years, so it’s important we select the right ERP, QMS & MES partner as we take our next step towards the next 50 years,” explains Stewart Mclaughlin, manufacturing director at Warmflow. “Like any company we face operational challenges, and Rockwell Automation gives us a solution to these with its Plex software all-in-one solution. Its forecasting gives us room for advancement too, as we will be able to better schedule our highly qualified engineers and designers for more R&D work on our new, more-sustainable geothermal and heat-pump technologies.”
All elements of this digital solution integrate seamlessly with each other, with further operational value added by a unified LifecycleIQ Services contract for the hardware and software solutions, giving Warmflow a single point of contact for support for its new digitalized infrastructure.
About Rockwell AutomationRockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 29,000 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing Connected Enterprise to life across industrial enterprises, visit www.rockwellautomation.com.
Logo – https://mma.prnewswire.com/media/1981317/Rockwell_Automation_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/warmflow-to-see-more-actionable-real-time-operational-insights-and-better-forecasting-with-plex-smart-manufacturing-platform-from-rockwell-automation-302151516.html

Continue Reading

Trending